These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31507338)

  • 1. Cost-effectiveness of the use of the continuous subcutaneous insulin infusion pump versus daily multiple injections in type 1 diabetes adult patients at the Mexican Institute of Social Security.
    Doubova SV; Roze S; Ferreira-Hermosillo A; Pérez-Cuevas R; Gasca-Pineda R; Barsoe C; Baran J; Ichihara B; Gryzbowski E; Jones K; Valencia JE
    Cost Eff Resour Alloc; 2019; 17():19. PubMed ID: 31507338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of continuous subcutaneous insulin infusion versus multiple daily insulin for treatment of children with type 1 diabetes.
    Zhang L; Leng X; Tian F; Xiao D; Xuan J; Yang H; Liu J; Chen Z
    Postgrad Med; 2022 Aug; 134(6):627-634. PubMed ID: 35695267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.
    Cohen N; Minshall ME; Sharon-Nash L; Zakrzewska K; Valentine WJ; Palmer AJ
    Pharmacoeconomics; 2007; 25(10):881-97. PubMed ID: 17887808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcome and Cost-Effectiveness Analysis of CSII Versus MDI in Children and Adolescent With Type 1 Diabetes Mellitus in a Public Health Care System of China.
    Hu S; Yang H; Chen Z; Leng X; Li C; Qiao L; Lv W; Li T
    Front Endocrinol (Lausanne); 2021; 12():604028. PubMed ID: 33859614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Patients with Poorly Controlled Type 2 Diabetes in Finland.
    Roze S; Smith-Palmer J; Delbaere A; Bjornstrom K; de Portu S; Valentine W; Honkasalo M
    Diabetes Ther; 2019 Apr; 10(2):563-574. PubMed ID: 30730036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK.
    Roze S; Valentine WJ; Zakrzewska KE; Palmer AJ
    Diabet Med; 2005 Sep; 22(9):1239-45. PubMed ID: 16108855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
    J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of sensor-augmented pump therapy versus standard insulin pump therapy in patients with type 1 diabetes in Denmark.
    Roze S; de Portu S; Smith-Palmer J; Delbaere A; Valentine W; Ridderstråle M
    Diabetes Res Clin Pract; 2017 Jun; 128():6-14. PubMed ID: 28432898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-effectiveness analysis of continuous subcutaneous insulin injection versus multiple daily injections in type 1 diabetes patients: a third-party US payer perspective.
    St Charles M; Lynch P; Graham C; Minshall ME
    Value Health; 2009; 12(5):674-86. PubMed ID: 19171006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands.
    Roze S; Smith-Palmer J; de Portu S; Delbaere A; de Brouwer B; de Valk HW
    Clinicoecon Outcomes Res; 2019; 11():73-82. PubMed ID: 30679914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes.
    Jendle J; Pöhlmann J; de Portu S; Smith-Palmer J; Roze S
    Diabetes Technol Ther; 2019 Mar; 21(3):110-118. PubMed ID: 30785311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden.
    Jendle J; Smith-Palmer J; Delbaere A; de Portu S; Papo N; Valentine W; Roze S
    Diabetes Ther; 2017 Oct; 8(5):1015-1030. PubMed ID: 28871565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States.
    Biskupiak JE; Ramos M; Levy CJ; Forlenza G; Hopley C; Boyd J; Swift D; Lamotte M; Brixner DI
    J Manag Care Spec Pharm; 2023 Jul; 29(7):807-817. PubMed ID: 37133431
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
    Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
    Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
    Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
    BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and economic benefits of integrated pump/CGM technology therapy in patients with type 1 diabetes in Colombia.
    Gomez AM; Alfonso-Cristancho R; Orozco JJ; Lynch PM; Prieto D; Saunders R; Roze S; Valencia JE
    Endocrinol Nutr; 2016 Nov; 63(9):466-474. PubMed ID: 27595241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial.
    Pollard DJ; Brennan A; Dixon S; Waugh N; Elliott J; Heller S; Lee E; Campbell M; Basarir H; White D;
    BMJ Open; 2018 Apr; 8(4):e016766. PubMed ID: 29627802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: a Health Economic Analysis in Sweden.
    Jendle J; Buompensiere MI; Holm AL; de Portu S; Malkin SJP; Cohen O
    Diabetes Ther; 2021 Nov; 12(11):2977-2991. PubMed ID: 34596879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Event and Cost Offsets of Switching 20% of the Type 1 Diabetes Population in Germany From Multiple Daily Injections to Continuous Subcutaneous Insulin Infusion: A 4-Year Simulation Model.
    Zöllner YF; Ziegler R; Stüve M; Krumreich J; Schauf M
    J Diabetes Sci Technol; 2016 Sep; 10(5):1142-8. PubMed ID: 26902790
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.